Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 32OTHER 15NIH 7NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 16Magnetic Resonance Spectroscopy 13Vincristine 8Dexamethasone 6Cyclophosphamide 6Radiotherapy 5Radiation 5Leucovorin 5Lenalidomide 5Doxorubicin 5Cisplatin 5Calcium Dobesilate 5dexamethasone acetate 4dexamethasone 21-phosphate 4daratumumab 4auricularum 4X-Rays 4Standard of Care 4Radiotherapy, Conformal 4Practice Guidelines as Topic 4Etoposide 4Cytarabine 4Bortezomib 4Biopsy 4pegaspargase 3Taxes 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3Prednisone 3Platinum 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Cetuximab × 30 days × Clear all
NCT05863195 2026-06-01

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Eastern Cooperative Oncology Group

Phase 3 Recruiting
408 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02438722 2026-05-18

S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

SWOG Cancer Research Network

Phase 2/3 Completed
174 enrolled 18 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡